SCHEMBL4515544

SCHEMBL4515544

O=S(=O)(NCc1ccnc2cc(Cl)ccc12)c1ccc(Br)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 2/20 0.46
▸ MAPT P10636 3/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ USP2 O75604 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ XBP1 P17861 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ NPC1 O15118 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ CYP1A2 P05177 2/20 0.43
▸ PAX8 Q06710 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ TAAR1 Q96RJ0 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4496515 0.85 CYP19A1 (0.46) CYP19A1MAPTMEN1KMT2AL3MBTL1
SCHEMBL4508326 0.82 CYP19A1 (0.50) CYP19A1MEN1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL4498319 0.77 CYP19A1 (0.48) CYP19A1MEN1LMNAKMT2AL3MBTL1
SCHEMBL15819557 0.75 MAPT (0.45) CYP19A1MAPTLMNASMN1; SMN2NPC1
SCHEMBL15643545 0.74 CYP19A1 (0.44) CYP19A1MAPTMEN1LMNAKMT2A
SCHEMBL3253962 0.74 GAA (0.44) LMNASMN1; SMN2ALDH1A1HTT
SCHEMBL4514444 0.74 CYP19A1 (0.44) CYP19A1MAPTMEN1LMNAKMT2A
SCHEMBL4513829 0.72 CYP19A1 (0.48) CYP19A1MEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL15643340 0.72 ALDH1A1 (0.42) CYP19A1MAPTSMN1; SMN2NPC1ALDH1A1
SCHEMBL6873025 0.72 KMT5B (0.61) MAPTMEN1USP2LMNAXBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090029855-A1 Quinoline Derivatives and Their Use as Pesticides BASF SE (DE) 2009-01-29 — — US disclosed
EP-2007727-A1 QUINOLINE DERIVATIVES AND THEIR USE AS PESTICIDES BASF SE (DE) 2008-12-31 — — EP disclosed
WO-2007104726-A1 QUINOLINE DERIVATIVES AND THEIR USE AS PESTICIDES BASF SE (DE) 2007-09-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029855-A1 Quinoline Derivatives and Their Use as Pesticides CBR3, HCRTR1, HCAR3 CYP19A1 1573/4885MAPT 4868/4885MEN1 2744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback